Bio

Scott Fisher joined Pleasant Bay as a Managing Director in 2013. He brings over seventeen years of private equity, M&A, and corporate strategy experience to the firm, primarily in the healthcare and life sciences sectors but also in business services and technology. Scott has a successful track record of working with companies to drive equity value creation. Prior to joining Pleasant Bay, Scott was a Partner and co-founder of Centerstone Partners, an independent sponsor private equity firm where he led all aspects of the firm’s investment activities. At Centerstone, Scott helped build and finance several healthcare and life sciences companies as a founder, investor, operator and advisor, including Amerigen Pharmaceuticals, Theorem Clinical Research, and Cuda Pharmaceuticals among others. He sourced and executed these proprietary investment opportunities, working in close partnership with other institutional investors. Scott has served on the Boards of and advised numerous private companies, and his experience spans both domestic and emerging markets. Previously, Scott was the Director of Corporate Development at Fisher Scientific International, where he led mergers and acquisitions for Fisher’s healthcare and diagnostics businesses. Prior to Fisher Scientific, Scott worked at Bain & Company, focusing on growth strategies and private equity engagements. Scott began his career in private equity at First Union Capital Partners, where he executed middle-market leveraged buyout and growth equity investments.